Experts argue preventative screening should become new standard of care

In an editorial in the journal Frontiers in Neurology, two leading multiple sclerosis (MS) experts are advocating for genetic testing to identify MS patients who are at higher risk of developing a devastating side effect from their medications.

Results published in Frontiers in Neurology may lead to an 11% reduction in PML caused by immune-modifying medications

New research has confirmed a strong link between four genetic mutations and progressive multifocal leukoencephalopathy (PML), a rare but often fatal brain infection that can be triggered by dozens of FDA-approved drugs.

Population Bio (PB) – a global leader in gene discovery announced, in support of World Rare Disease Day, its continued investment in its CNV Beacon® gene discovery platform which delivers new knowledge about rare diseases.

Population Diagnostics – a global leader in gene discovery for complex disease announced today that it is changing its corporate name to Population Bio.

Collaboration Announced Between Researchers at University of California Irvine and Population Diagnostics,
Inc. at Rare Disease Event in Southern California